Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CORONARY ARTERY DISEASE

Myocardial viability and CABG surgery: a Bayesian appraisal of STICH

The myocardial viability substudy from the STICH trial has reaffirmed the 10-year survival benefit of CABG surgery in patients with left ventricular dysfunction, but whether myocardial viability must be present for the long-term benefits of revascularization to be realized remains inconclusive.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Influence of myocardial viability on cardiovascular death after CABG surgery.

References

  1. Braunwald, E. & Rutherford, J. D. Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J. Am. Coll. Cardiol. 8, 1467–1470 (1986).

    Article  CAS  Google Scholar 

  2. Allman, K. C. et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol. 39, 1151–1158 (2002).

    Article  Google Scholar 

  3. Camici, P. G., Prasad, S. K. & Rimoldi, O. E. Stunning, hibernation, and assessment of myocardial viability. Circulation 117, 103–114 (2008).

    Article  Google Scholar 

  4. Orlandini, A. et al. Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies. Int. J. Cardiol. 182, 494–499 (2015).

    Article  Google Scholar 

  5. Panza, J. A. et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N. Engl. J. Med. 381, 739–748 (2019).

    Article  Google Scholar 

  6. Beanlands, R. S. et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J. Am. Coll. Cardiol. 50, 2002–2012 (2007).

    Article  Google Scholar 

  7. Cleland, J. G. et al. The Heart Failure Revascularisation Trial (HEART). Eur. J. Heart Fail. 13, 227–233 (2011).

    Article  Google Scholar 

  8. Alosh, M. et al. Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials. Stat. Med. 36, 1334–1360 (2017).

    Article  Google Scholar 

  9. Patel, H. et al. Myocardial viability-state of the art: is it still relevant and how to best assess it with imaging? Trends Cardiovasc. Med. 28, 24–37 (2018).

    Article  Google Scholar 

  10. Page, B. J. et al. Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia. J. Am. Coll. Cardiol. 65, 684–697 (2015).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregg W. Stone.

Ethics declarations

Competing interests

The authors declare no competing interests

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Redfors, B., Stone, G.W. Myocardial viability and CABG surgery: a Bayesian appraisal of STICH. Nat Rev Cardiol 16, 702–703 (2019). https://doi.org/10.1038/s41569-019-0292-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41569-019-0292-0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing